Transcutaneous Neuromodulation improved inflammation and sympathovagal ratio in patients with primary biliary ssscholangitis and inadequate response to Ursodeoxycholic acid: a pilot study.

BMC Complement Med Ther · 2020 · PMC7395375 · PMID 32738911

Europe PMC DOI

hedged sentences

0.0680

closest p · 1.4× alpha

0.0740

boldest claim

The sentences

showed a trendP = 0.068so close (0.05 < p ≤ 0.1)

Plasma level of TNF-α in PBC patients (3.90(3.90 ~ 42.65) pg/ml) after TN combined with UDCA (less than 4 pg/ml) showed a trend of decrease ( P = 0.068), which was not seen after sham-TN combined with UDCA (3.90(3.90 ~ 14.70)pg/ml) ( P > 0.05).

also in 53,322 other papers

an increasing trendP = 0.074so close (0.05 < p ≤ 0.1)

After sham-TN combined with UDCA, the level of CA and DCA showed an increasing trend ( P = 0.074, P = 0.059), and the remaining 11 subtypes of bile acids showed no significant changes (P > 0.05).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.